FONTANA DILETTA

Ruolo: 
Assegnista di ricerca
Settore scientifico disciplinare: 
MALATTIE DEL SANGUE (MED/15)

Pubblicazioni

  • Bossi, E., Aroldi, A., Brioschi, F., Steidl, C., Baretta, S., Renso, R., et al. (2020). Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy. AMERICAN JOURNAL OF HEMATOLOGY. Dettaglio
  • Nucera, S., Fazio, G., Piazza, R., Rigamonti, S., Fontana, D., Gambacorti Passerini, C., et al. (2020). Germ-Line TP53 Mutation in an Adolescent With CMML/Atypical CML and Familiar Cancer Predisposition. HEMASPHERE, 4(5), e460. Dettaglio
  • Fontana, D., Mauri, M., Renso, R., Docci, M., Crespiatico, I., Rost, L., et al. (2020). ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine. NATURE COMMUNICATIONS, 11(1). Dettaglio
  • Fontana, D., Mauri, M., Renso, R., Docci, M., Crespiatico, I., Rost, L., et al. (2020). ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine. BLOOD, 136(Supplement_2), LBA-5-LBA-5. Dettaglio
  • (2019). Characterization of the role of mutated ETNK1 in the onset of atypical Chronic Myeloid Leukemia. (Tesi di dottorato, Università degli Studi di Milano-Bicocca, 2019). Dettaglio